Epilogue On Esperion Therapeutics (Rating Downgrade)
Esperion Therapeutics Inc ESPR
$3.13
▲ +0.00%
(+$0.00)
Open
$3.13
Prev Close
$3.13
Day Range
$3.12 – $3.14
52W Range
$0.76 – $4.18
Market Cap
$805.76M
Beta
1.03
EPS (TTM)
$-0.06
📋 Company Profile
| Industry | Pharmaceuticals |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2013-06-24 |
| Shares Out. | 257,430,000 |
| Website | esperion.com/ ↗ |
| Phone | 13026587581 |
Esperion Therapeutics Inc is a publicly traded company under the ticker symbol ESPR on the NASDAQ NMS - GLOBAL MARKET, operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
14 analysts (2026-05-01)
📰 Latest News for ESPR
Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
ESPR Stock Surges 44% in a Month: Here's What You Need to Know
Esperion Announces Two New Analyses Supporting Bempedoic Acid to Reduce LDL-C Levels to be Presented at the European Atherosclerosis Society (EAS) Congress 2026
Esperion Therapeutics To Present Two New Analyses On Various Applications Of Bempedoic Acid At The European Atherosclerosis Society (EAS) Congress 2026 May 24-27